About Martin Pieprzyk
Form D filings for LevitasBio from 2017 to 2024 list Martin Pieprzyk as chief executive officer and director.
Martin Pieprzyk first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Martin Pieprzyk in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Martin Pieprzyk works with at each company, as listed on that company's latest Form D.
LevitasBio, Inc. · Form D, Apr 10, 2024
ST
Steve Tablak
Director
PM
Paul Meister
Director
GH
Greg Herrema
Director
SG
Sandy Gardiner
Director
VJ
Victor Tong, Jr.
Director